Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$1.24M Buy
1,870
+163
+10% +$119K 0.09% 102
2024
Q4
$1.18M Buy
1,707
+76
+5% +$54.6K 0.09% 97
2024
Q3
$1.36M Buy
1,631
+216
+15% +$193K 0.09% 95
2024
Q2
$1.45M Buy
1,415
+163
+13% +$157K 0.12% 91
2024
Q1
$1.22M Buy
1,252
+21
+2% +$18.6K 0.11% 91
2023
Q4
$932K Buy
1,231
+525
+74% +$347K 0.09% 93
2023
Q3
$416K Buy
706
+246
+53% +$163K 0.04% 133
2023
Q2
$333K Sell
460
-137
-23% -$93.1K 0.04% 139
2023
Q1
$406K Sell
597
-58
-9% -$37.2K 0.05% 122
2022
Q4
$358K Buy
655
+4
+0.6% +$2.1K 0.04% 126
2022
Q3
$270K Sell
651
-12
-2% -$6.01K 0.04% 110
2022
Q2
$316K Hold
663
0.05% 94
2022
Q1
$443K Buy
+663
New +$444K 0.06% 84

Other funds holding ASML

Callan Capital's ASML Position: Q1 2025 in Review

Callan Capital increased its ASML (ASML) stake by 9.5% in Q1 2025, buying an estimated $119K and bringing the position to 1,870 shares worth $1.24M. The position accounts for 0.09% of the portfolio, ranked #102.

Callan Capital first reported a position in ASML in Q1 2022 and has held it in 13 quarters since. The position peaked at $1.45M in Q2 2024. 1,622 funds tracked by Wall St. Rank hold ASML as of Q1 2025.

  • Callan Capital held 1,870 shares of ASML worth $1.24M as of Q1 2025.
  • Callan Capital bought 163 ASML shares in Q1 2025, an estimated $119K.
  • ASML made up 0.09% of Callan Capital's portfolio in Q1 2025, its #102 holding.
  • Callan Capital first reported a position in ASML in Q1 2022 and has held it in 13 quarters since.
  • Callan Capital's ASML position peaked at $1.45M in Q2 2024.
  • 1,622 funds tracked by Wall St. Rank held ASML as of Q1 2025.

Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.